Relation of C-Reactive Protein and New-Onset Atrial Fibrillation in Patients With Acute Myocardial Infarction

American Journal of Cardiology

Volumn 100, Issue 5, 2007, Pages 753-757

  Aronson, Doron ^a   Boulos, Monther ^a   Suleiman, Abeer ^a   Bidoosi, Salma ^a   Agmon, Yoram ^a   Kapeliovich, Michael ^a   Beyar, Rafael ^a   Markiewicz, Walter ^a   Hammerman, Haim ^a   Suleiman, Mahmoud ^a  

^a RAMBAM MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HOSPITALIZATION; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SYMPTOMATOLOGY; SYSTEMIC DISEASE; TISSUE INJURY;

AGE FACTORS; AGED; ATRIAL FIBRILLATION; C-REACTIVE PROTEIN; COHORT STUDIES; CREATININE; FEMALE; FOLLOW-UP STUDIES; FORECASTING; HOSPITALIZATION; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PATIENT READMISSION; PROSPECTIVE STUDIES; SEX FACTORS; STROKE VOLUME; TIME FACTORS;

EID: 34547948732     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.04.014     Document Type: Article

References (28)

1. Anzai T., Yoshikawa T., Shiraki H., Asakura Y., Akaishi M., Mitamura H., and Ogawa S. C-reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q-wave acute myocardial infarction. Circulation 96 (1997) 778-784
2. Suleiman M., Khatib R., Agmon Y., Mahamid R., Boulos M., Kapeliovich M., Levy Y., Beyar R., Markiewicz W., Hammerman H., and Aronson D. Early inflammation and risk of long-term development of heart failure and mortality in survivors of acute myocardial infarction: predictive role of C-reactive protein. J Am Coll Cardiol 47 (2006) 962-968
3. James S., Oldgren J., Lindback J., Johnston N., Siegbahn A., and Wallentin L. An acute inflammatory reaction induced by myocardial damage is superimposed on a chronic inflammation in unstable coronary artery disease. Am Heart J 149 (2005) 619-626
4. Nian M., Lee P., Khaper N., and Liu P. Inflammatory cytokines and postmyocardial infarction remodeling. Circ Res 94 (2004) 1543-1553
5. Ravelli F., and Allessie M. Effects of atrial dilatation on refractory period and vulnerability to atrial fibrillation in the isolated Langendorff-perfused rabbit heart. Circulation 96 (1997) 1686-1695
6. Lehto M., Snapinn S., Dickstein K., Swedberg K., and Nieminen M.S. Prognostic risk of atrial fibrillation in acute myocardial infarction complicated by left ventricular dysfunction: the OPTIMAAL experience. Eur Heart J 26 (2005) 350-356
7. Rathore S.S., Berger A.K., Weinfurt K.P., Schulman K.A., Oetgen W.J., Gersh B.J., and Solomon A.J. Acute myocardial infarction complicated by atrial fibrillation in the elderly: prevalence and outcomes. Circulation 101 (2000) 969-974
8. Crenshaw B.S., Ward S.R., Granger C.B., Stebbins A.L., Topol E.J., and Califf R.M. Atrial fibrillation in the setting of acute myocardial infarction: the GUSTO-I experience. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries. J Am Coll Cardiol 30 (1997) 406-413
9. Engelmann M.D., and Svendsen J.H. Inflammation in the genesis and perpetuation of atrial fibrillation. Eur Heart J 26 (2005) 2083-2092
10. Boos C.J., Anderson R.A., and Lip G.Y. Is atrial fibrillation an inflammatory disorder?. Eur Heart J 27 (2006) 136-149
11. Aviles R.J., Martin D.O., Apperson-Hansen C., Houghtaling P.L., Rautaharju P., Kronmal R.A., Tracy R.P., Van Wagoner D.R., Psaty B.M., Lauer M.S., and Chung M.K. Inflammation as a risk factor for atrial fibrillation. Circulation 108 (2003) 3006-3010
12. Chung M.K., Martin D.O., Sprecher D., Wazni O., Kanderian A., Carnes C.A., Bauer J.A., Tchou P.J., Niebauer M.J., Natale A., and Van Wagoner D.R. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation 104 (2001) 2886-2891
13. Dernellis J., and Panaretou M. Relationship between C-reactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillation. Eur Heart J 25 (2004) 1100-1107
14. Conway D.S., Buggins P., Hughes E., and Lip G.Y. Prognostic significance of raised plasma levels of interleukin-6 and C-reactive protein in atrial fibrillation. Am Heart J 148 (2004) 462-466
15. Malouf J.F., Kanagala R., Al Atawi F.O., Rosales A.G., Davison D.E., Murali N.S., Tsang T.S., Chandrasekaran K., Ammash N.M., Friedman P.A., and Somers V.K. High sensitivity C-reactive protein: a novel predictor for recurrence of atrial fibrillation after successful cardioversion. J Am Coll Cardiol 46 (2005) 1284-1287
16. Kumagai K., Nakashima H., and Saku K. The HMG-CoA reductase inhibitor atorvastatin prevents atrial fibrillation by inhibiting inflammation in a canine sterile pericarditis model. Cardiovasc Res 62 (2004) 105-111
17. Frustaci A., Chimenti C., Bellocci F., Morgante E., Russo M.A., and Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 96 (1997) 1180-1184
18. Siu C.W., Lau C.P., and Tse H.F. Prevention of atrial fibrillation recurrence by statin therapy in patients with lone atrial fibrillation after successful cardioversion. Am J Cardiol 92 (2003) 1343-1345
19. Cusack M.R., Marber M.S., Lambiase P.D., Bucknall C.A., and Redwood S.R. Systemic inflammation in unstable angina is the result of myocardial necrosis. J Am Coll Cardiol 39 (2002) 1917-1923
20. Suleiman M., Aronson D., Reisner S.A., Kapeliovich M.R., Markiewicz W., Levy Y., and Hammerman H. Admission C-reactive protein levels and 30-day mortality in patients with acute myocardial infarction. Am J Med 115 (2003) 695-701
21. Kitsis R.N., and Jialal I. Limiting myocardial damage during acute myocardial infarction by inhibiting C-reactive protein. N Engl J Med 355 (2006) 513-515
22. Bruins P., te Velthuis H., Yazdanbakhsh A.P., Jansen P.G., van Hardevelt F.W., de Beaumont E.M., Wildevuur C.R., Eijsman L., Trouwborst A., and Hack C.E. Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation 96 (1997) 3542-3548
23. Gaudino M., Andreotti F., Zamparelli R., Di Castelnuovo A., Nasso G., Burzotta F., Iacoviello L., Donati M.B., Schiavello R., Maseri A., and Possati G. The -174G/C interleukin-6 polymorphism influences postoperative interleukin-6 levels and postoperative atrial fibrillation. Is atrial fibrillation an inflammatory complication?. Circulation 108 suppl 1 (2003) II195-II199
24. Patti G., Chello M., Candura D., Pasceri V., D'Ambrosio A., Covino E., and Di Sciascio G. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery. Results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) Study. Circulation 114 (2006) 1455-1461
25. Mihm M.J., Yu F., Carnes C.A., Reiser P.J., McCarthy P.M., Van Wagoner D.R., and Bauer J.A. Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation 104 (2001) 174-180
26. Lagrand W.K., Visser C.A., Hermens W.T., Niessen H.W., Verheugt F.W., Wolbink G.J., and Hack C.E. C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon?. Circulation 100 (1999) 96-102
27. Pepys M.B., Hirschfield G.M., Tennent G.A., Gallimore J.R., Kahan M.C., Bellotti V., Hawkins P.N., Myers R.M., Smith M.D., Polara A., et al. Targeting C-reactive protein for the treatment of cardiovascular disease. Nature 440 (2006) 1217-1221
28. Wijffels M.C., Kirchhof C.J., Dorland R., and Allessie M.A. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 92 (1995) 1954-1968